Loading...
Loading...
India's furosemide imports from POLAND total $213 across 16 shipments from 2 foreign suppliers. TEVA GYOGYSZERGYAR leads with $140 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include LOTUS LABS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for furosemide — a concentrated sourcing relationship with select suppliers from POLAND.

TEVA GYOGYSZERGYAR is the leading Furosemide supplier from POLAND to India, with import value of $140 across 2 shipments. The top 5 suppliers — TEVA GYOGYSZERGYAR, Teva Pharmaceutical Works Ltd. — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TEVA GYOGYSZERGYAR | $140 | 2 | 65.7% |
| 2 | Teva Pharmaceutical Works Ltd. | $73 | 14 | 34.3% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | LOTUS LABS PRIVATE LIMITED | $140 | 2 | 65.7% |
| 2 | WATSON PHARMA PRIVATE LIMITED | $73 | 14 | 34.3% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Furosemide suppliers from POLAND to India include TEVA GYOGYSZERGYAR, Teva Pharmaceutical Works Ltd.. The leading supplier is TEVA GYOGYSZERGYAR with import value of $140 USD across 2 shipments. India imported Furosemide worth $213 USD from POLAND in total across 16 shipments.
India imported Furosemide worth $213 USD from POLAND across 16 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Furosemide sourced from POLAND include LOTUS LABS PRIVATE LIMITED, WATSON PHARMA PRIVATE LIMITED. The largest buyer is LOTUS LABS PRIVATE LIMITED with $140 in imports across 2 shipments.
The total value of Furosemide imports from POLAND to India is $213 USD, across 16 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
16 Verified Shipments
2 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists